Winner of APAC MedTech Forum 2023 (Myopia Prevention Theme)
Invited member of JLABS Singapore, Johnson & Johnson’s global innovation ecosystem
Vision, redefined.
From Singapore to the world.
We are Maxight
MAXIGHT is a MedTech startup born in Singapore’s innovation ecosystem in 2023.
Our mission? Empowering the next generation with clearer vision — through breakthrough digital therapies and next-gen eye-friendly displays.
We combine cutting-edge optics, immersive display technology, and medically validated digital therapies to tackle one of the world’s fastest-growing epidemics: myopia.
We don’t just create devices. We build intelligent, eye-safe ecosystems that fit seamlessly into daily life — whether at home, in school, or on screen.
What We Do
Why It Matters
The world is facing a myopia crisis.
By 2050, half the global population will be myopic — many of them children. And as digital devices become essential to modern learning, parents are stuck between two hard choices: let their kids fall behind, or risk their vision.
We’re here to change that. With MAXIGHT, children can stay engaged in a digital world without compromising their visual health.
At the 2024 Fragrant Hill Conference, our approach was recognized for its potential to reshape how we prevent and manage childhood myopia.
• Eliminates transient myopia (NITM)
• Reduces axial elongation
• Improves diopter and choroidal thickness
• Boosts treatment adherence with immersive, non-invasive protocols
Conducting ongoing clinical research and regulatory certification with Singapore’s Health Sciences Authority (HSA)
What’s Next
Contact
Dr Ivy Zhang
+65 8741 8921 (WhatsApp)
zhangjh.aivi@maxightvision.com
